Drug Type CAR-T |
Synonyms anti-GPRC5D CAR T-cell therapy ( Bristol Myers Squibble) |
Target |
Action- |
Mechanism GPRC5D inhibitors(G-protein coupled receptor family C group 5member D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Relapse multiple myeloma | Phase 1 | United States | 30 Jan 2022 |